US Critical Metals Corp
USCM
Mydecine Innovations Group Inc
MYCO
Three Valley Copper Corp
TVC.H
Tuga Innovations Inc
TUGA
Windfall Geotek Inc
WIN
CA Stock MarketDetailed Quotes
GAU Galiano Gold Inc
- 1.980
- +0.080+4.21%
15min DelayMarket Closed Dec 3 16:00 ET
509.01MMarket Cap0.00P/E (TTM)
2.010High1.900Low180.91KVolume1.900Open1.900Pre Close355.01KTurnover2.73052wk High0.12%Turnover Ratio257.08MShares0.82052wk Low--EPS TTM298.14MFloat Cap9.590Historical High12.45P/E (Static)150.58MShs Float0.080Historical Low0.159EPS LYR5.79%Amplitude--Dividend TTM1.50P/B1Lot Size--Div YieldTTM
Galiano Gold Inc Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 71.13M | 63.96M | 31.7M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --71.13M | --63.96M | --31.7M | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | 127,668.57%44.72M | 107,858.33%38.87M | 27.05M | -2.78%35K | -2.70%36K | 0 | ||||
| Gross profit | 75,560.00%26.41M | 69,816.67%25.1M | 4.65M | 2.78%-35K | 2.70%-36K | 0 | ||||
| Operating expense | 40.48%4.1M | 159.99%9.32M | 61.94%8.52M | 38.24%17.3M | 42.72%5.57M | -21.95%2.92M | 77.25%3.58M | 82.17%5.26M | -11.39%12.51M | 16.79%3.9M |
| Selling and administrative expenses | -40.08%1.7M | 112.02%6.6M | 100.81%7.66M | 37.71%15.29M | 86.44%5.53M | -17.95%2.83M | 58.21%3.11M | 40.48%3.81M | -17.64%11.1M | -7.95%2.96M |
| -Selling and marketing expense | ---- | 56.46%460K | 5.02%272K | ---- | ---- | ---- | 10.94%294K | 204.71%259K | ---- | ---- |
| -General and administrative expense | -40.08%1.7M | 117.81%6.14M | 107.79%7.39M | 37.71%15.29M | 86.44%5.53M | -17.95%2.83M | 65.57%2.82M | 35.17%3.56M | -17.64%11.1M | -7.95%2.96M |
| Depreciation amortization depletion | ---- | ---- | -5.56%34K | ---- | ---- | ---- | ---- | -2.70%36K | ---- | ---- |
| -Depreciation and amortization | ---- | ---- | -5.56%34K | ---- | ---- | ---- | ---- | -2.70%36K | ---- | ---- |
| Other operating expenses | 2,859.26%2.4M | 476.27%2.72M | -41.26%830K | 42.38%2.01M | -95.42%43K | -71.17%81K | 758.18%472K | 931.39%1.41M | 119.78%1.41M | 675.21%938K |
| Operating profit | 856.47%22.32M | 535.91%15.78M | 26.33%-3.88M | -38.24%-17.3M | -44.04%-5.46M | 21.77%-2.95M | -75.81%-3.62M | -82.17%-5.26M | 11.39%-12.51M | -17.40%-3.79M |
| Net non-operating interest income (expenses) | -149.40%-372K | -170.81%-1.71M | -41.53%390K | 185.88%2.88M | 104.70%754K | -79.62%753K | 1,985.34%2.42M | 1,861.76%667K | 390.73%1.01M | -144.32%-16.05M |
| Non-operating interest income | 70.09%1.29M | --2K | 26.15%849K | 179.83%2.9M | 42.67%759K | 124.56%759K | --0 | 1,465.12%673K | 303.11%1.04M | 1,109.09%532K |
| Non-operating interest expense | 41,750.00%1.67M | 28,580.00%1.43M | 8,320.00%421K | -32.00%17K | 300.00%4K | -50.00%4K | -28.57%5K | -44.44%5K | -21.88%25K | 109.09%1K |
| Total other finance cost | -650.00%-11K | 111.59%281K | 3,700.00%38K | 20.00%6K | -99.99%1K | 100.06%2K | ---2.42M | --1K | -75.00%5K | 150.31%16.58M |
| Other net income (expenses) | -253.42%-20.84M | -139.78%-5.24M | -109.72%-1.27M | -22.58%40.5M | -102.17%-1.05M | 901.18%13.59M | -9.28%13.16M | 893.10%13.09M | 195.17%52.31M | 159.51%48.34M |
| Gain on sale of security | -861.51%-19.11M | -625.64%-3.87M | -245.22%-3.43M | 161.67%3.47M | 30.94%-3.86M | 10,558.33%2.51M | -94.42%737K | 21,390.91%2.36M | -537.80%-5.62M | -561.23%-5.59M |
| Special income (charges) | ---1.73M | ---1.36M | ---2.55M | -106.30%-378K | ---378K | --0 | --0 | --0 | 178.67%6M | ---- |
| -Less:Restructuring and mergern&acquisition | --1.73M | --1.48M | --2.55M | --378K | --378K | --0 | --0 | --0 | --0 | ---- |
| -Less:Impairment of capital assets | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --1.63M | ---- |
| -Less:Write off | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -200.00%-7.63M | ---- |
| -Gain on sale of business | --0 | --118K | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
| Income before tax | -90.34%1.1M | -26.17%8.83M | -156.03%-4.76M | -36.08%26.09M | -120.20%-5.76M | 789.77%11.39M | -4.81%11.96M | 652.57%8.49M | 159.24%40.81M | 131.31%28.5M |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | -90.34%1.1M | -26.17%8.83M | -156.03%-4.76M | -36.08%26.09M | -120.20%-5.76M | 789.77%11.39M | -4.81%11.96M | 652.57%8.49M | 159.24%40.81M | 131.31%28.5M |
| Net income continuous operations | -90.34%1.1M | -26.17%8.83M | -156.03%-4.76M | -36.08%26.09M | -120.20%-5.76M | 789.77%11.39M | -4.81%11.96M | 652.57%8.49M | 159.24%40.81M | 131.31%28.5M |
| Noncontrolling interests | 0 | 0 | 0 | 0 | 0 | 0 | ||||
| Net income attributable to the company | -90.34%1.1M | -26.17%8.83M | -156.03%-4.76M | -36.08%26.09M | -120.20%-5.76M | 789.77%11.39M | -4.81%11.96M | 652.57%8.49M | 159.24%40.81M | 131.31%28.5M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -90.34%1.1M | -26.17%8.83M | -156.03%-4.76M | -36.08%26.09M | -120.20%-5.76M | 789.77%11.39M | -4.81%11.96M | 652.57%8.49M | 159.24%40.81M | 131.31%28.5M |
| Diluted earnings per share | -91.44%0.0043 | -40.00%0.03 | -150.00%-0.02 | -33.33%0.12 | -115.38%-0.02 | 400.00%0.05 | -16.67%0.05 | 500.00%0.04 | 158.06%0.18 | 131.71%0.13 |
| Basic earnings per share | -91.60%0.0042 | -40.00%0.03 | -150.00%-0.02 | -33.33%0.12 | -115.38%-0.02 | 400.00%0.05 | -16.67%0.05 | 500.00%0.04 | 158.06%0.18 | 131.71%0.13 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.